Membrane proteins are the gateway to cells and are involved in many critical functions. Each membrane protein is unique, and their complexity makes it difficult to fit into a standardized expression ...
Nuclera has announced a $12million extension to its Series C round which raised $75m in October 2024. The raise was led by ...
Additional $12M financing led by Elevage Medical Technologies and Jonathan Milner alongside existing investors British Business Bank, and GK Goh -- The funding will accelerate development of eProtein ...
Following the installation of eProtein Discovery at leading academic institutes across the UK and Europe 1, the expansion ...
Microbial systems offer distinct advantages in protein expression, saving costs and time, and offering well-characterized host genetics and ease of scale-up. 2 However, challenges remain in process ...
The purification of proteins and antibodies is a critical process in biotechnology and pharmaceutical industries. Traditional methods often involve single-use materials, leading to high costs and ...
Cambridge biotech Nuclera has boosted its Series C round to $87 million after securing a further $12m from a range of backers ...
Osaka Metropolitan University researchers elucidated molecular crosstalk between lactoferrin and IgGFcγBP, revealing ...
Nuclera has expanded its Series C funding round to USD $87 million following a new USD $12 million extension led by Elevage ...
The funding will support further development of eProtein Discovery to enable full-format antibody expression, purification, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback